Harbor Capital Advisors’s Precision BioSciences DTIL Stock Holding History

Harbor Capital Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,991	Closed	-$54.7K	–	775
2023 Q4	$54.7K	Buy	4,991 +571	+13%	+$6.16K	0.01%	433
2023 Q3	$45.3K	Buy	4,420 +708	+19%	+$10.9K	0.01%	437
2023 Q2	$58.6K	Buy	3,712 +340	+10%	+$7.77K	0.01%	479
2023 Q1	$76.2K	Sell	3,372 -294	-8%	-$9.69K	0.02%	240
2022 Q4	$131K	Sell	3,666 -79	-2%	-$3.12K	0.13%	83
2022 Q3	$1.47M	Buy	3,745 +610	+19%	+$29K	1.35%	23
2022 Q2	$150K	Sell	3,135 -191	-6%	-$11.2K	0.11%	110
2022 Q1	$307K	Sell	3,326 -701	-17%	-$95.2K	0.14%	83
2021 Q4	$894K	Buy	+4,027	New	+$1.12M	0.33%	78

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Harbor Capital Advisors's DTIL Position: Q1 2024 in Review

Harbor Capital Advisors sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 4,991 shares — an estimated $54.7K sold.

Harbor Capital Advisors first reported a position in DTIL in Q4 2021 and held it in 9 quarters. The position peaked at $1.47M in Q3 2022. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Harbor Capital Advisors reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
Harbor Capital Advisors sold 4,991 Precision BioSciences shares in Q1 2024, an estimated $54.7K.
Harbor Capital Advisors first reported a position in Precision BioSciences in Q4 2021 and held it in 9 quarters.
Harbor Capital Advisors's Precision BioSciences position peaked at $1.47M in Q3 2022.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.